NEW YORK (GenomeWeb) - Goldman Sachs on Wednesday downgraded shares of Myriad Genetics to a Sell rating and Exact Sciences to Neutral, while upgrading Alere to Neutral.

The bank maintained its stock ratings for Hologic, Cepheid, and T2 Biosystems.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.